期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Recent discoveries and emerging therapeutics in eosinophilic esophagitis 被引量:3
1
作者 aakash goyal Edaire Cheng 《World Journal of Gastrointestinal Pharmacology and Therapeutics》 CAS 2016年第1期21-32,共12页
Eosinophilic esophagitis(Eo E) is an allergy-mediated disease culminating in severe eosinophilic inflammation and dysfunction of the esophagus. This chronic disorder of the esophagus causes significant morbidity, poor... Eosinophilic esophagitis(Eo E) is an allergy-mediated disease culminating in severe eosinophilic inflammation and dysfunction of the esophagus. This chronic disorder of the esophagus causes significant morbidity, poor quality of life, and complications involving fibrosis and esophageal remodeling. Overlapping features between EoE and gastroesophageal reflux disease(GERD) pose great challenges to differentiating the two conditions, although the two disorders are not mutually exclusive. Recent findings suggest that the confounding condition proton pump inhibitor- responsive esophageal eosinophilia(PPI-REE) is likely a subset of EoE. Since PPIs have therapeutic properties that can benefit EoE, PPIs should be considered as a therapeutic option for Eo E rather than a diagnostic screen to differentiate GERD, PPIREE, and EoE. Other current treatments include dietary therapy, corticosteroids, and dilation. Immunomodulators and biologic agents might have therapeutic value, and larger trials are needed to assess efficacy and safety. Understanding the pathophysiology of EoE is critical to the development of novel therapeutics. 展开更多
关键词 EOSINOPHILIC ESOPHAGITIS INTERLEUKIN-5 PROTON PUMP inhibitors PROTON PUMP inhibitor-responsive esophageal EOSINOPHILIA Gastroesophageal reflux disease Eotaxin-3
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部